Amplia Therapeutics Correlations
| INNMF Stock | USD 0.06 0.01 14.49% |
The correlation of Amplia Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Amplia Therapeutics Correlation With Market
Good diversification
The correlation between Amplia Therapeutics Limited and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Amplia Therapeutics Limited and DJI in the same portfolio, assuming nothing else is changed.
Amplia |
The ability to find closely correlated positions to Amplia Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amplia Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amplia Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amplia Therapeutics Limited to buy it.
Moving against Amplia Pink Sheet
| 0.51 | GM | General Motors Aggressive Push | PairCorr |
| 0.48 | BRK-B | Berkshire Hathaway | PairCorr |
| 0.46 | ZM | Zoom Video Communications | PairCorr |
| 0.42 | MRVL | Marvell Technology Earnings Call This Week | PairCorr |
| 0.4 | RCAT | Red Cat Holdings Trending | PairCorr |
| 0.37 | ALAB | Astera Labs, Common | PairCorr |
| 0.32 | ADSK | Autodesk | PairCorr |
Related Correlations Analysis
Please specify at least 3 valid symbols having historical data to build a meaningful correlation cloud. You can use symbol search above to locate your securities.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Amplia Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Amplia Therapeutics Corporate Management
| Hamish George | Chief Officer | Profile | |
| Benjamin Segal | Clinical Consultant | Profile | |
| BSc BSc | MD CEO | Profile | |
| Frank Gelder | Founding Scientist | Profile | |
| James Taylor | Trials Consultant | Profile | |
| TerrieAnne Cock | Head Biology | Profile | |
| Frederick Reno | Toxicology Consultant | Profile |